Arrow Pharmaceuticals to Issue IPO; Appoints Global IME Capital as Issue Manager

Arrow Pharmaceuticals is preparing to launch its Initial Public Offering (IPO) to the general public, marking a significant step in its expansion and investment strategy.

The company plans to issue 1.5 million units of ordinary shares at a face value of Rs 100 per share. To facilitate the IPO process, Arrow Pharmaceuticals has appointed Global IME Capital as the official issue manager.

An agreement to this effect was signed on April 10 at the premises of Global IME Capital. The deal was formalized by Udhab Prasad Mainali, Chairman of Arrow Pharmaceuticals, and Mandip Luitel, CEO of Global IME Capital.

Arrow Pharmaceuticals currently operates with an authorized capital of Rs 1 billion and an issued capital of Rs 750 million. The company’s corporate office is located in Ward No. 3, Basundhara, Kathmandu Municipality, while its manufacturing facility is based in Sudal, Bhaktapur.